About Fizimed
Fizimed is a company based in Strasbourg (France) founded in 2017 by Emeline Hahn, Julien Guay, Allan Mabilais, and Paul Grandemange. Fizimed has raised $4.35 million across 1 funding round from investors including UNIQA Group, Bpifrance and UI Investissement. Fizimed operates in a competitive market with competitors including Axonics, Laborie Medical, Amber Therapeutics, NeuSpera Medical and Atlantic Therapeutics, among others.
- Total Equity Funding$4.35M (USD)
in 1 rounds
- Latest Funding Round$4.35M (USD), Series A
Mar 2025
- InvestorsUNIQA Group
& 2 more
Apps and channels of Fizimed
Fizimed publishes 2 mobile apps with over 100K+ downloads; its YouTube channel Fizimed has 2.54K subscribers.
Funding Insights of Fizimed
Fizimed has successfully raised a total of $4.35M through 1 strategic funding round. The most recent funding activity was a Series A round of $4.35 million completed in March 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $4.35M
- Total Rounds 1
- Last Round Series A — $4.35M
- First Round $4.35M
(Mar 2025)
- Investors Count 3
All 1 funding rounds of Fizimed with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2025 | $4.35M | Series A | – | – |
3 investors in total: 3 institutional.
Investors in Fizimed
Fizimed has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include UNIQA Group, Bpifrance and UI Investissement.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
UI Investissement is engaged in private equity and investment services. | – | ui-investissement.com | Paris, France | |
Diversified insurance firm | 1999 | uniqagroup.com | Vienna, Austria | |
Corporate consultancy, advisory, and funding services are provided to businesses. | 2012 | bpifrance.com | Maisons Alfort, France |
Investor details for Fizimed
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Fizimed
4 people are tracked at Fizimed (4 in leadership).
| Name | Role | Group |
|---|---|---|
Emeline Hahn | Co-Founder & CEO | Leadership |
Julien Guay | Co-Founder & CPO | Leadership |
Allan Mabilais | Co-Founder & CTO | Leadership |
Paul Grandemange | Co-Founder | Leadership |
Complete people profiles for Fizimed
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Fizimed
2 dated milestones of Fizimed across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Fizimed is founded.
- Funding First funding round of $4.4M.
Competitors of Fizimed
Fizimed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Axonics, Laborie Medical, Amber Therapeutics, NeuSpera Medical and Atlantic Therapeutics, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| axonics.com | 2013 | Irvine, United States | $143.47M | 762 | Sacral neuromodulation devices are developed for urinary and bowel control. | |
| laborie.com | 1967 | Mississauga, Canada | – | 617 | Medical products for female lower urinary tract dysfunctions are provided. | |
| amber-tx.com | 2021 | London, United Kingdom | $100M | – | Bioelectrical therapies for peripheral nervous system disorders are developed. | |
| neuspera.com | 2014 | Santa Clara, United States | $123.59M | – | Miniaturized injectable neuromodulation devices are developed for chronic diseases. | |
| atlantictherapeutics.com | 2013 | Oranmore, Ireland | $70.62M | – | Non-invasive wearable devices for pelvic floor strengthening are developed. | |
| uromems.com | 2011 | Grenoble, France | $85.73M | – | Developer of active implantable devices for urological incontinence | |
| chiaro.co.uk | 2013 | London, United Kingdom | $1.8M | 87 | Devices for pelvic floor muscle strengthening are developed by Chiaro. | |
| americanmedicalsystems.com | 1972 | Minnetonka, United States | – | – | Devices for the treatment of pelvic disorders | |
| leveemedical.com | 2021 | Durham, United States | $24.15M | – | Urological devices for post-prostatectomy incontinence are developed by Levee Medical. |
Detailed competitors of Fizimed
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Fizimed
The website of Fizimed (fizimed.com) receives about 57.4K visits a month.
- Monthly visits57.4K
▲ 32.5% vs previous month
Websites whose visitors overlap most with Fizimed. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| mylittlepessaire.com | 100% | – | #1,665,912 | View details | |
perineeshop.com | perineeshop.com | 99% | – | #560,776 | – |
parasanteonline.fr | parasanteonline.fr | 88% | – | #330,852 | – |
ag-ggup.de | ag-ggup.de | 86% | – | #2,973,965 | – |
bernard-bruno-masseur-kinesitherapeute.fr | bernard-bruno-masseur-kinesitherapeute.fr | 85% | – | #1,947,254 | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Fizimed
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Fizimed
Complete news archive for Fizimed
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Fizimed
10 companies that operate in the same segment as Fizimed (Health Monitoring & Wearables), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Smart fitness equipment and streaming platforms are provided. | 2011 | New York, New York, United States | USD 995.53 M | USD 2.45 B | 2,660 | |
Connected devices for health, sleep, and activity monitoring are developed. | 2008 | Moulineaux, Seine-maritime, France | USD 93.83 M | – | – | |
Internet first brand offering wearable breast pumps | 2013 | London, England, United Kingdom | USD 157.63 M | – | – | |
Metabolic health is tracked via devices and fitness platforms. | 2019 | Bengaluru, Karnataka, India | USD 163.28 M | USD 65.48 M | 274 | |
Health-tracking smart rings and biosensors are developed for biometric monitoring. | 2013 | Oulu, North Ostrobothnia, Finland | USD 1.32 B | – | – | |
Wearable glucose monitoring patches are provided for real-time data tracking. | 1999 | San Diego, California, United States | USD 52.5 M | USD 4.66 B | 10,300 | |
AI-based mobile app tracks and predicts menstrual cycles. | 2015 | London, England, United Kingdom | USD 269 M | – | – | |
Smartphone-enabled glucometers and diabetes management apps are provided. | 2015 | Delhi, Delhi, India | USD 50.83 M | USD 2.74 M | 142 | |
Provider of a fertility tracking app that doubles as birth control | 2013 | Stockholm, Sweden | USD 99.5 M | – | – | |
Diabetes management is enabled via glucose meters and mobile apps. | 2010 | Palo Alto, California, United States | USD 201 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Fizimed
Fizimed was founded in 2017 and raised its 1st funding round 8 years after it was founded.
Fizimed is headquartered in Strasbourg, France. It is registered at Strasbourg, Grand Est, France.
Emeline Hahn is the current CEO of Fizimed. They have also founded this company.
Fizimed is a funded company, having raised a total of $4.35M across 1 funding round to date. The company's 1st funding round was a Series A of $4.35M, raised on Mar 2025.
Fizimed was founded in 2017 in Strasbourg, France, and operates in the medical device sector. The Emy device, a wireless probe linked to a mobile application, is produced for perineal rehabilitation. It supports home-based exercises that supplement practitioner-led sessions, with progress monitored remotely by healthcare providers. Operations focus on enabling independent patient training while integrating with professional care protocols.
Fizimed's top competitors include Axonics, NeuSpera Medical and Laborie Medical.
Fizimed has 3 investors. Key investors include UNIQA Group, Bpifrance, and UI Investissement.
Fizimed operates through Fizimed.
Yes. Fizimed publishes Emy - Kegel exercises and 1 more app, with over 100,000 downloads.